DIA 2016 Annual Meeting

Component Type: Workshop
Level: Intermediate

This session will provide an overview of the use of MedDRA and Standardised MedDRA Queries in the review of New Drug Applications. It will include practical exercises designed to promote discussion of best practices and solutions to challenges in premarketing pharmacovigilance. Participants will gain a valuable insight into how FDA analyzes MedDRA data, with an emphasis on data quality.

**Due to session format, seating will be limited to 50 participants and available on a first come, first served basis. Once all seats are occupied, DIA will be required to close the session, and no more participants will be admitted. Interested attendees are encouraged to arrive early in order to ensure seating.

Chair

David Richardson, MD

Speaker

Facilitator
Christopher Damian Breder